ibrutinib

Italy

Drugs containing this active substance

  • IMBRUVICA

    It is used for the treatment of certain blood cancers in adult patients: mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenström's macroglobulinemia (WM).

    Form: capsules, hard gelatin

    Active substance Dosage
    ibrutinib -

    ATC: L01EL01

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.